CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 78 filers reported holding CONCERT PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.72 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $219,000 | -62.1% | 43,959 | -3.8% | 0.00% | -100.0% |
| Q4 2020 | $578,000 | +49.0% | 45,719 | +15.7% | 0.00% | 0.0% |
| Q3 2020 | $388,000 | -14.9% | 39,506 | -13.8% | 0.00% | 0.0% |
| Q2 2020 | $456,000 | +27.7% | 45,815 | +13.5% | 0.00% | 0.0% |
| Q1 2020 | $357,000 | +13.3% | 40,349 | +18.0% | 0.00% | 0.0% |
| Q4 2019 | $315,000 | +57.5% | 34,194 | +0.6% | 0.00% | – |
| Q3 2019 | $200,000 | -46.2% | 33,984 | +9.7% | 0.00% | -100.0% |
| Q2 2019 | $372,000 | +0.3% | 30,986 | +0.8% | 0.00% | 0.0% |
| Q1 2019 | $371,000 | -5.4% | 30,743 | -1.7% | 0.00% | 0.0% |
| Q4 2018 | $392,000 | +20.2% | 31,261 | +42.4% | 0.00% | 0.0% |
| Q3 2018 | $326,000 | -10.4% | 21,948 | +1.4% | 0.00% | 0.0% |
| Q2 2018 | $364,000 | -9.2% | 21,637 | +23.5% | 0.00% | 0.0% |
| Q1 2018 | $401,000 | -10.1% | 17,513 | +1.5% | 0.00% | 0.0% |
| Q4 2017 | $446,000 | +47.7% | 17,248 | -15.6% | 0.00% | 0.0% |
| Q3 2017 | $302,000 | +6.7% | 20,448 | +1.0% | 0.00% | 0.0% |
| Q2 2017 | $283,000 | -11.6% | 20,253 | +8.0% | 0.00% | 0.0% |
| Q1 2017 | $320,000 | +74.9% | 18,753 | +5.5% | 0.00% | – |
| Q4 2016 | $183,000 | +3.4% | 17,777 | +1.8% | 0.00% | – |
| Q3 2016 | $177,000 | -8.8% | 17,458 | +1.2% | 0.00% | -100.0% |
| Q2 2016 | $194,000 | -4.4% | 17,248 | +16.3% | 0.00% | 0.0% |
| Q1 2016 | $203,000 | -27.2% | 14,834 | +0.8% | 0.00% | 0.0% |
| Q4 2015 | $279,000 | +8.1% | 14,709 | +6.9% | 0.00% | 0.0% |
| Q3 2015 | $258,000 | +31.6% | 13,754 | +4.4% | 0.00% | 0.0% |
| Q2 2015 | $196,000 | – | 13,180 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| L1 Capital Pty Ltd | 1,050,124 | $10,312,000 | 3.31% |
| Alambic Investment Management, L.P. | 19,934 | $196,000 | 2.15% |
| INGALLS & SNYDER LLC | 1,363,603 | $13,391,000 | 0.92% |
| ACUTA CAPITAL PARTNERS, LLC | 300,000 | $2,946,000 | 0.80% |
| RA Capital Management | 1,858,474 | $18,250,000 | 0.33% |
| Perceptive Advisors | 2,150,641 | $21,119,000 | 0.31% |
| SPHERA FUNDS MANAGEMENT LTD. | 310,000 | $3,044,000 | 0.30% |
| Eversept Partners, LP | 103,829 | $1,019,601 | 0.23% |
| Opaleye Management Inc. | 100,000 | $982,000 | 0.19% |
| GSA CAPITAL PARTNERS LLP | 58,095 | $570,000 | 0.10% |